Optical Biometry Devices Market Report Scope & Overview:

The Optical Biometry Devices Market was valued at USD 395.00 Million in 2025 and is expected to reach USD 694.12 Million by 2035, growing at a CAGR of 5.80% from 2026-2035.

The Optical Biometry Devices Market is seeing growth on account of an increase in cataract procedures globally, declining use of ultrasound-based biometry techniques, and increased availability of state-of-the-art diagnostic equipment for eye conditions. Optical measuring techniques like swept source optical coherence tomography and optical low-coherence interferometry are becoming popular owing to their fast and accurate measurement capabilities, as well as improved intraocular lens calculation even in challenging scenarios. An aging population and an increased prevalence of refractive errors have been increasing the need for pre-surgery measurement. Reimbursement policies in certain major health markets are also supporting the adoption of these devices.

On April 4, 2024, Carl Zeiss Meditec AG completed its USD 1.07 billion acquisition of Dutch Ophthalmic Research Center (D.O.R.C.). The transaction expanded ZEISS Medical Technology’s ophthalmic portfolio and strengthened its integrated surgical and diagnostic capabilities, reflecting the industry’s shift toward digitally connected ophthalmic workflows beyond standalone optical biometry devices.

Optical Biometry Devices Market Trends

• Swept-source OCT-based optical biometers are increasingly displacing partial coherence interferometry platforms as the technology of choice for premium cataract practices.

• Rising adoption of image-guided biometry that connects preoperative measurement directly to intraoperative surgical guidance systems is streamlining cataract workflows.

• Outpatient migration of cataract procedures toward ambulatory surgical centers is expanding demand for compact, high-throughput biometry devices.

• Growing use of multiple IOL power calculation formulas, including AI-assisted models, within a single biometer is becoming a key purchasing differentiator.

• Expanding cataract surgical volumes across Asia Pacific are driving demand for cost-competitive, locally manufactured optical biometers.

• Device manufacturers are increasingly bundling biometers with corneal topography and dry eye assessment tools into unified preoperative diagnostic stations.

U.S. Optical Biometry Devices Market Outlook

The U.S. Optical Biometry Devices Market was valued at USD 125.23 Million in 2025 and is expected to reach USD 199.32 Million by 2035, growing at a CAGR of 4.76% from 2026-2035.

The U.S. Optical Biometry Devices Market growth continues to be reinforced by the country's high annual cataract surgery volume, well-established Medicare and private payer reimbursement for optical biometry as a covered preoperative diagnostic, and a dense concentration of high-volume ambulatory surgical centers performing premium IOL procedures. Surgeons across the country continue to favor swept-source OCT biometers for their ability to reduce surgical planning errors and improve refractive outcomes, while device manufacturers headquartered or with major operations in the United States maintain close feedback loops with leading cataract and refractive surgery practices that accelerate iterative product improvements.

On July 23, 2024, Bausch + Lomb acquired Trukera Medical from AccelMed Partners, strengthening its surgical diagnostics portfolio with the ScoutPro tear osmolarity system. The acquisition supports preoperative dry-eye assessment before cataract surgery and expands Bausch + Lomb’s U.S. surgical diagnostics capabilities, complementing biometry and intraocular lens planning technologies.

Optical Biometry Devices Market Segment Analysis

• By Product, the SS-OCT-based Optical Biometers segment dominated the Optical Biometry Devices Market with approximately 52.40% share in 2025, while the OLCR-based Optical Biometers segment is the fastest growing with a CAGR of approximately 7.85%.

• By Product Type, the Non-contact Type segment dominated the Optical Biometry Devices Market with approximately 68.20% share in 2025, while the Contact Type segment is the fastest growing with a CAGR of approximately 7.65%.

• By Application, the Cataract Surgery & IOL Power Calculation segment dominated the Optical Biometry Devices Market with approximately 74.60% share in 2025, while the Refractive Surgery segment is the fastest growing with a CAGR of approximately 8.45%.

• By End User, the Hospitals segment dominated the Optical Biometry Devices Market with approximately 54.30% share in 2025, while the Ambulatory Surgical Centers segment is the fastest growing with a CAGR of approximately 8.10%.

By Product, SS-OCT-based Optical Biometers Dominates and OLCR-based Optical Biometers Grows Fastest

SS-OCT-based optical biometers remain the preferred technology among high-volume cataract practices because swept-source OCT achieves markedly higher measurement success rates in dense cataracts and in eyes with unusually short or long axial lengths, cases where older interferometry-based platforms frequently fail to obtain a usable reading. Surgeons value the whole-eye, cornea-to-retina imaging these devices provide, which supports more confident surgical planning and reduces the need for supplemental contact ultrasound measurements, reinforcing SS-OCT as the default premium purchase for cataract-focused surgical centers.

OLCR-based optical biometers are expanding at the fastest pace as mid-tier and community ophthalmology practices seek a balance between measurement precision and instrument cost that swept-source platforms do not always offer. This segment benefits from single-step, multi-parameter scanning that reduces chair time relative to older technologies, and it is gaining particular traction among practices upgrading from legacy interferometry devices without committing to the highest price tier, positioning OLCR as an accessible entry point into modern optical biometry.

By Product Type, Non-contact Type Dominates and Contact Type Grows Fastest

Optical non-contact biometers dominate the market owing to the absence of need for corneal applanation and the anesthesia procedure involved in the case of contact ultrasound-based biometers. The benefits include a lower infection risk, reduced discomfort on the part of the patients, and elimination of any kind of variability associated with the compressions of the globe.

Contact type products are experiencing the highest growth but from a lower base due to the fact that they are clinically required for cases where there are dense cataracts or corneal opacities or where eye fixation is difficult, thus making the reception of optical signals difficult. Contact-based biometer as a fallback method is clinically essential in such cases. The contact type segment is looking forward to complement the non-contact type segment rather than replace it.

By Application, Cataract Surgery & IOL Power Calculation Dominates and Refractive Surgery Grows Fastest

Cataract surgery and IOL power calculation represent the core application of optical biometry, reflecting the sheer global volume of cataract procedures performed annually and the direct link between biometric measurement accuracy and postoperative refractive outcomes. Surgical practices treat biometry as a mandatory preoperative step for every cataract case, embedding device utilization into standard surgical scheduling and sustaining continuous replacement and service demand across hospitals and surgical centers alike.

Refractive surgery is expanding at the fastest pace as biometric measurement becomes increasingly important for planning premium and toric IOL implantation as well as corneal refractive procedures that require precise axial length and keratometry data. This segment benefits from rising patient demand for spectacle independence and growing surgeon adoption of advanced IOL formulas that require higher-precision biometric inputs, positioning refractive-focused practices as an increasingly important growth channel for device manufacturers.

By End User, Hospitals Dominate and Ambulatory Surgical Centers Grow Fastest

Hospitals account for the biggest demand as a result of the significant numbers of surgeries performed at these facilities, diverse patient population that features comorbidities, as well as the requirement to equip several ophthalmological rooms with the diagnostic equipment at the same time. When it comes to big hospitals, it is not unusual to standardize the use of one biometer model throughout all departments.

Ambulatory surgical centers are growing fastest as cataract procedure volumes continue shifting toward lower-cost outpatient settings that offer faster patient turnover and more predictable scheduling. This segment focuses on compact, high-throughput biometers that fit space-constrained procedure suites, and it benefits from the broader trend of same-day cataract surgery expansion, making it an increasingly attractive channel for manufacturers targeting recurring service and software upgrade revenue.

Regional Analysis

North America Optical Biometry Devices Market Insights

North America accounted for approximately 38.90% of the global Optical Biometry Devices Market in 2025, the largest share of any region, supported by high cataract surgical volumes, comprehensive reimbursement for optical biometry as a covered diagnostic procedure, and a concentration of leading device manufacturers headquartered or operating major commercial units in the region. The United States drives the substantial majority of regional demand, reflecting its dense network of high-volume ambulatory surgical centers and academic ophthalmology programs performing premium and complex cataract procedures.

Canada contributes a smaller but steadily growing share of regional revenue, aided by provincial investment in surgical wait-time reduction programs and gradual replacement of older interferometry-based biometers across public hospital ophthalmology departments. Distribution agreements and multi-year service contracts continue to shape regional competitive dynamics as vendors work to defend installed-base share in an increasingly mature and consolidated market.

Europe Optical Biometry Devices Market Insights

Europe is the second-largest regional market, which includes Germany, the United Kingdom, and France as the key players in this region. Demand will be driven by procurement from centralized health systems, compliance with the EU Medical Device Regulation, and advanced research activity that has traditionally ensured early adoption of biometry devices in Europe's key academic eye centers.

Germany ranks first regarding regional adoption due to the well-developed private and public infrastructure of ophthalmology in the country and the headquarters location of major device companies, whereas the UK National Health Service continues efforts for the implementation of pre-op diagnostics for cataracts in trusts within its cataract pathways efficiency program. The growing tendency of conference product launch events in this region (new diagnostic devices launched during major European ophthalmology congresses) will keep strengthening competitive position of suppliers.

Asia Pacific Optical Biometry Devices Market Insights

Asia Pacific is the fastest-growing regional market, projected to expand at a CAGR of approximately 9.85% between 2026 and 2035, driven by a rapidly aging population, rising cataract surgery volumes, and expanding government investment in eye care infrastructure across China and India. China represents the largest national market within the region, supported by rapid hospital construction and a growing base of domestic optical biometer manufacturers offering cost-competitive alternatives to established international brands.

India and the broader Southeast Asian market are contributing an increasing share of regional growth as private eye care chains expand surgical capacity and cataract surgical rates rise in previously underserved rural populations. Japan continues to represent a mature, technology-forward market characterized by early adoption of precision swept-source biometers, while government-backed vision health programs across the region are extending access to optical biometry beyond tier-one hospitals into secondary and tertiary eye care facilities.

MEA & Latin America Optical Biometry Devices Market Insights

In the Middle East and Africa, the lead countries are the GCC countries, where government-driven construction of hospitals and specialty eye care investments in Saudi Arabia and the United Arab Emirates have led to an uptake of advanced optical biometers in newly built eye surgery centers. South Africa is the region’s top market among African countries, backed by a relatively well-developed private ophthalmology infrastructure, but regional penetration is hampered by disparities in access to eye surgery infrastructure.

In Latin America, Brazil is the leader, having posted the highest revenues due to its large private and public ophthalmology base as well as the growing number of cataracts that are done via public health programs and private insurance. Mexico comes second in terms of revenues, aided by increasing private health care investments in the country, while Latin American penetration has been picking up steam amid efforts from health ministries in individual countries to reduce their cataract backlog.

Market Dynamics

Growth Drivers: Rising Cataract Surgical Volumes and the Shift to Optical Measurement

Growth in the Optical Biometry Devices Market is fundamentally supported by the rising global volume of cataract surgeries and the continued clinical shift away from contact ultrasound biometry toward faster, more accurate, and more comfortable optical measurement technology. Optical biometers deliver materially higher measurement success rates and better repeatability than ultrasound-based methods, directly improving IOL power prediction accuracy and reducing postoperative refractive surprises, a clinical advantage that continues to justify device upgrades even in cost-conscious healthcare systems.

An aging global population requiring a higher volume of cataract interventions, combined with favorable reimbursement conditions for optical biometry services in several major markets, is reinforcing sustained procurement of biometry equipment. Rising patient expectations around premium and toric IOL outcomes are further expanding the addressable base for higher-precision biometers capable of supporting advanced IOL power calculation formulas.

Restraints: High Device Costs and Workflow Integration Barriers

The significant initial cost of swept-source OCT biometers—sometimes in excess of tens of thousands of dollars per instrument even before service agreements—makes it quite difficult for smaller facilities and clinics working under healthcare budgets to adopt them. The cost associated with service agreements in addition to licensing software or IOL power formulae make up the cost of ownership, which compels many smaller practices to delay upgrading to newer equipment or continue using old interferometer machines far past their optimal replacement period.

The implementation of newer biometry instruments in existing surgical settings may cause temporary efficiency loss, as they take time to retrofit, install, validate and train staff to operate them. The complication caused by regulation differences among various national medical device regimes in addition to validating new IOL power formulas against previous surgeon outcome records makes the process of replacing the machine rather difficult in an otherwise continually growing market.

Opportunities: AI-Assisted Formulas and Emerging Market Expansion

The integration of artificial intelligence-assisted IOL power calculation formulas directly within optical biometers represents a significant opportunity, as surgeons increasingly seek devices that combine measurement with more predictive, outcome-optimized surgical planning in a single platform. Manufacturers that successfully bundle biometry with corneal topography, dry eye assessment, and image-guided surgical planning are well positioned to capture a larger share of the preoperative diagnostic workflow.

Expanding cataract surgical capacity and healthcare infrastructure investment across Asia Pacific, the Middle East, and Latin America offers device manufacturers a substantial runway for geographic expansion beyond mature North American and European markets. Rising local manufacturing capability in China and India is also creating opportunities for cost-competitive optical biometers tailored to public hospital procurement budgets, broadening access to modern biometry technology in previously underserved markets.

Recent Developments:

• 2025: Tomey Corporation received FDA 510(k) clearance for its Optical Biometer OA-2000, expanding U.S. availability of cleared non-invasive biometry solutions for precise intraocular lens power calculations before cataract surgery.

• 2025: Haag-Streit globally launched the Elara 900 slit lamp and Refractor 900 digital phoropter at ESCRS, strengthening its preoperative ophthalmic diagnostic portfolio alongside its established optical biometry platforms.

• 2023: Alcon reported 50% new placement share in the U.S. for its ARGOS Biometer with Image Guidance, highlighting continued expansion of its cataract refractive diagnostic portfolio.

• 2023: Bausch + Lomb acquired AcuFocus, adding the IC-8 Apthera small-aperture extended-depth-of-focus IOL and strengthening its premium cataract surgery portfolio requiring precise preoperative optical biometry.

Optical Biometry Devices Market Key Players

• Carl Zeiss Meditec AG

• Alcon Inc.

• Haag-Streit AG

• Topcon Healthcare (Topcon Corporation)

• Nidek Co., Ltd.

• Tomey Corporation

• Bausch + Lomb Corporation

• Movu, Inc. (a Santec company)

• AMETEK, Inc. (Reichert Technologies)

• Canon Inc.

• Optikon 2000 S.p.A.

• Lumibird Medical (Quantel Medical)

• Heine Optotechnik GmbH & Co. KG

• Appasamy Associates

• Meridian AG

• DGH Technology, Inc.

• Sonomed Escalon

• Visionix (Luneau Technology Group)

• Righton Co., Ltd.

• Suzhou VANOPTIC Precision Instrument Co., Ltd.

Optical Biometry Devices Market Report Scope: